Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2
Authors:
- Roko P.A. NikolicRNRoko P.A. Nikolic
- Jordi Pardo PardoJPJordi Pardo Pardo
- Janet E. PopeJPJanet E. Pope
- Claire E.H. BarberCBClaire E.H. Barber
- Cheryl BarnabeCBCheryl Barnabe
- Orit SchieirOSOrit Schieir
- Shahin JamalSJShahin Jamal
- Alexandra LeggeALAlexandra Legge
- Pooneh AkhavanPAPooneh Akhavan
- J. Carter ThorneJTJ. Carter Thorne
- Claire BombardierCBClaire Bombardier
Open Access
- 15 July 2024
- journal article
- letter
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 51 (9) , 940-941
Abstract
We have updated the Canadian Rheumatology Association (CRA) guidelines for rheumatoid arthritis (RA) with 3 recommendations for the use of glucocorticoids (GCs). The recommendations address the use of short-term GCs for RA flares or as bridging therapy when disease-modifying antirheumatic drugs (DMARDs) are initiated or changed, and the use of longterm GCs as adjuncts to DMARDs.Keywords
This publication has 4 references indexed in Scilit:
- Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1The Journal of Rheumatology, 2023
- Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic DrugsThe Journal of Rheumatology, 2022
- Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidanceBMJ Evidence-Based Medicine, 2022
- GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENTJournal of Clinical Epidemiology, 2017